Heart shield: cholesterol drug may prevent Chemo-Induced cardiac damage

NCT ID NCT07254221

First seen Dec 08, 2025 · Last updated May 15, 2026 · Updated 20 times

Summary

This study tests whether rosuvastatin, a cholesterol-lowering drug, can prevent heart damage in women with breast cancer receiving anthracycline chemotherapy. 400 participants will take either rosuvastatin or a placebo daily for 12 months. The main goal is to see if the drug helps maintain heart pumping function and reduces signs of heart injury.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Kowsar Hospital, Fars Heart Foundation

    Shiraz, Fars, Iran

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Modarres Hospital, Shahid Beheshti University of Medical Sciences

    Tehran, Tehran Province, Iran

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Motahari Breast Cancer Clinic

    Shiraz, Fars, 71344-1864, Iran

    Contact Email: •••••@•••••

  • Rajaee Hospital, Iran University of Medical Sciences

    Tehran, Tehran Province, Iran

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sina Hospital, Tehran University of Medical Sciences

    Tehran, Tehran Province, Iran

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Taleghani Hospital, Shahid Beheshti University of Medical Sciences

    Tehran, Tehran Province, Iran

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Toba Oncology Department, Mazandaran University of Medical Sciences

    Sari, Mazandaran, Iran

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.